Prevalence and clinicopathological features of driver gene mutations profile in BCR:ABL1 negative classical myeloproliferative neoplasm—A single-center study from North India
Indian Journal of Pathology and Microbiology · 2024
DOI: 10.4103/ijpm.ijpm_743_23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pathology and Microbiology, 2024. Verfasst von Khaliqur Rahman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, SGPGI, Lucknow, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Janus Kinase 2, Mutation, Calreticulin, Receptors, Thrombopoietin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
Recurrent somatic mutations in the JAK2 , CALR , and the MPL genes are noted in BCR:ABL1 negative classic myeloproliferative neoplasms (MPN) that includes polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofibrosis (PMF). Materials and Methods: Mutation profile and clinical features of MPN cases diagnosed at a tertiary care center in North India are being described. JAK2V617F mutation was screened using ARMS PCR, and CALR mutation was screened using allele-specific PCR followed by fragment analysis. MPL and JAK2 Exon 12 mutations were screened by Sanger sequencing. Some of the samples were also screened using commercial kits based on single-plex RT PCR.
Results
A total of 378 cases (including 124 PV, 121 ET, and 133 PMF cases) were screened over 6.5 years. JAK2V617F mutation was noted in 90.3%, 61.1%, and 69.2% of cases of PV, ET, and PMF, respectively. In PV, JAK2V617F wild-type cases were associated with a significantly lower age (44 yrs vs 54 yrs; P = 0.001), lower TLC (6.3 vs 16.9; P = 0.001), and a lower platelet count (188 × 109/L vs 435 × 109/L; P = 0.009) as compared to the JAK2V617F mutated cases. CALR and MPL mutations were noted in 17.4% and 12% and 0.8% and 5.3% of ET and PMF cases, respectively. Type 1 CALR mutations were commoner in both ET and PMF. The triple negative cases constituted 20.7% and 13.5% cases of ET and PMF, respectively. In ET, the triple negative cases were found to have a significantly lower median age of presentation (42 yrs vs 52 yrs; P = 0.001), lower median TLC (10.2 × 109/L vs 13.2 × 109/L; P = 0.024), and a higher median platelet count (1238 × 109/L vs 906 × 109/L; P = 0.001) as compared to driver genes mutated cases. In PMF, the triple negative cases were found to have a significantly lower hemoglobin level (7.9 g/dl vs 11.0 gl/dl; P = 0.001) and a significant female preponderance ( P = 0.05) as compared to the mutated cases. CALR mutations were found to have a significantly lower median age (43 yrs vs 56 yrs; P = 0.001) and lower hemoglobin (9.6 g/dl vs 11.3 g/dl) as compared to the JAK2 mutations.
Conclusion
Our data on the driver gene mutational profile of BCR:ABL1 negative MPN is one of the largest patient cohorts. The prevalence and clinicopathological features corroborate with that of other Asian studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology, SGPGI, Lucknow, Uttar Pradesh, India.
Zitieren
APA
Rahman, K., Biswas, S., Sharma, A., Gupta, K., Chandra, D., Singh, M. K., Gupta, R., Mishra, A., Kumar, S., Gupta, A., Hasan, F., Nityanand, S., & Kahsyap, R. (2024). Prevalence and clinicopathological features of driver gene mutations profile in BCR:ABL1 negative classical myeloproliferative neoplasm—A single-center study from North India. Indian Journal of Pathology and Microbiology. https://doi.org/10.4103/ijpm.ijpm_743_23
Vancouver
Rahman K, Biswas S, Sharma A, Gupta K, Chandra D, Singh MK, et al. Prevalence and clinicopathological features of driver gene mutations profile in BCR:ABL1 negative classical myeloproliferative neoplasm—A single-center study from North India. Indian Journal of Pathology and Microbiology. 2024. doi:10.4103/ijpm.ijpm_743_23
BibTeX
@article{Rahman2024,
author = {Rahman, Khaliqur and Biswas, Seema and Sharma, Akhilesh and Gupta, Kusum and Chandra, Dinesh and Singh, Manish K and Gupta, Ruchi and Mishra, Ashish and Kumar, Sanjeev and Gupta, Anshul and Hasan, Faheema and Nityanand, Soniya and Kahsyap, Rajesh},
title = {Prevalence and clinicopathological features of driver gene mutations profile in BCR:ABL1 negative classical myeloproliferative neoplasm—A single-center study from North India},
journal = {Indian Journal of Pathology and Microbiology},
year = {2024},
doi = {10.4103/ijpm.ijpm_743_23}
}
EUVIMED